📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Alemtuzumab Treatment Leads to Delayed Recovery of T Follicular Regulatory Cells, and May Therefore Predispose Patients to de novo Donor-Specific Antibody Formation (2019)

First Author: Wallin E

Attributed to: The Role of Follicular T Cells in the Alloimmune Response and Alloantibody Formation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21926/obm.transplant.1903079

Publication URI: http://dx.doi.org/10.21926/obm.transplant.1903079

Type: Journal Article/Review

Parent Publication: OBM Transplantation

Issue: 3